{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:19Z","timestamp":1792791439317,"version":"4.5.0"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000027","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010707","name":"Canadian Bee Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013500","name":"Canadian Cardiovascular Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.smim.2026.102033","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:23:37Z","timestamp":1779139417000},"page":"102033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dendritic cells as central coordinators of oncolytic virus-induced antitumor immunity"],"prefix":"10.1016","volume":"82","author":[{"given":"Ehab M.","family":"Ezzaldeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu Vijay","family":"Vijayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethi Gopalakrishnan","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unnikrishnan Babukuttan","family":"Sheela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5427-0829","authenticated-orcid":false,"given":"Shashi","family":"Gujar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2026.102033_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer Journal Clinicians"},{"key":"10.1016\/j.smim.2026.102033_bib2","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA A Cancer Journal Clinicians"},{"key":"10.1016\/j.smim.2026.102033_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102033_bib5","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2026.102033_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1158\/2159-8290.CD-18-1357","article-title":"Cancer Vaccines: Steering T Cells Down the Right Path to Eradicate Tumors","volume":"9","author":"Ott","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.smim.2026.102033_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/OV.S145532","article-title":"Oncolytic virus and PD-1\/PD-L1 blockade combination therapy","volume":"7","author":"Chen","year":"2018","journal-title":"OV"},{"key":"10.1016\/j.smim.2026.102033_bib8","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221839","article-title":"Nutrients: Signal 4 in T cell immunity","volume":"221","author":"Raynor","year":"2024","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2026.102033_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","article-title":"Dendritic Cells Revisited","volume":"39","author":"Cabeza-Cabrerizo","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib10","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.smim.2026.102033_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101481","article-title":"The Role of Dendritic Cells in Cancer and Anti-Tumor Immunity","volume":"52","author":"Marciscano","year":"2021","journal-title":"Semin Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.smim.2026.102033_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102033_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2567.2009.03134.x","article-title":"Tumour-derived prostaglandin E2 and transforming growth factor-\u03b2 synergize to inhibit plasmacytoid dendritic cell-derived interferon-\u03b1","volume":"128","author":"Bekeredjian-Ding","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.smim.2026.102033_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104216","article-title":"Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint","volume":"83","author":"Verma","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.smim.2026.102033_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41423-021-00741-5","article-title":"Dendritic cells in cancer immunology","volume":"19","author":"Murphy","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.smim.2026.102033_bib18","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.cell.2019.01.051","article-title":"SnapShot: Cancer Immunotherapy with Oncolytic Viruses","volume":"176","author":"Gujar","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.smim.2026.102033_bib19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.smim.2026.102033_bib20","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.7150\/thno.58390","article-title":"Turning cold tumors into hot tumors by improving T-cell infiltration","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.smim.2026.102033_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41596-024-00985-1","article-title":"Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy","author":"Gujar","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.smim.2026.102033_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.mt.6300108","article-title":"History of oncolytic viruses: genesis to genetic engineering","volume":"15","author":"Kelly","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.smim.2026.102033_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.smim.2026.102033_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733506","article-title":"Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells","volume":"12","author":"Tijtgat","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan4220","article-title":"Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs","volume":"9","author":"Brown","year":"2017","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.smim.2026.102033_bib26","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ymthe.2020.01.027","article-title":"Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus","volume":"28","author":"Aref","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.smim.2026.102033_bib27","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1126\/science.282.5392.1332","article-title":"Reovirus Therapy of Tumors with Activated Ras Pathway","volume":"282","author":"Coffey","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102033_bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/1878-0261.13648","article-title":"Oncolytic adenoviruses and immunopeptidomics: a convenient marriage","volume":"18","author":"Garcia-Moure","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.smim.2026.102033_bib29","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1158\/1078-0432.CCR-17-0681","article-title":"Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte\u2013Associated Protein Blockade","volume":"23","author":"Moesta","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.smim.2026.102033_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008025","article-title":"Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102033_bib31","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3390\/cancers15071947","article-title":"Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment","volume":"15","author":"Gryciuk","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.smim.2026.102033_bib32","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"JCO"},{"key":"10.1016\/j.smim.2026.102033_bib33","article-title":"Recent advances in oncolytic virus combined immunotherapy in tumor treatment","volume":"12","author":"Zhou","year":"2025","journal-title":"Genes & Dis."},{"key":"10.1016\/j.smim.2026.102033_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib35","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","article-title":"A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments","volume":"24","author":"Barry","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.smim.2026.102033_bib36","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.smim.2026.102033_bib37","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2093054","article-title":"Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation","volume":"11","author":"He","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.smim.2026.102033_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13740","article-title":"Oncolytic herpes simplex virus propagates tertiary lymphoid structure formation via CXCL10\/CXCR3 to boost antitumor immunity","volume":"58","author":"Zhang","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.smim.2026.102033_bib39","doi-asserted-by":"crossref","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102033_bib40","article-title":"Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancer","author":"Mattiuz","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.smim.2026.102033_bib41","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.immuni.2011.08.013","article-title":"Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine","volume":"35","author":"Lewis","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib42","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.immuni.2020.04.005","article-title":"Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection","volume":"52","author":"Bosteels","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib43","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.immuni.2021.10.020","article-title":"Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity","volume":"55","author":"Duong","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib44","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1038\/s41467-022-34791-8","article-title":"Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity","volume":"13","author":"Svensson-Arvelund","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102033_bib45","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.165.11.6037","article-title":"BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood","volume":"165","author":"Dzionek","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib46","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.194.12.1823","article-title":"BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha\/beta induction","volume":"194","author":"Dzionek","year":"2001","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2026.102033_bib47","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.4049\/jimmunol.171.12.6466","article-title":"Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody","volume":"171","author":"Asselin-Paturel","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib48","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1182\/blood-2005-09-3842","article-title":"Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors","volume":"107","author":"Zhang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102033_bib49","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102033_bib50","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1084\/jem.20030162","article-title":"Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells","volume":"198","author":"Lund","year":"2003","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2026.102033_bib51","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1078-0432.CCR-12-2733","article-title":"Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells","volume":"19","author":"Guillerme","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.smim.2026.102033_bib52","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2010.11.020","article-title":"Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual","volume":"33","author":"Swiecki","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib53","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/s41590-025-02288-3","article-title":"Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections","volume":"26","author":"Ngo","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib54","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1158\/0008-5472.CAN-11-0367","article-title":"Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer","volume":"71","author":"Labidi-Galy","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.smim.2026.102033_bib55","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1158\/0008-5472.CAN-11-3468","article-title":"Impaired IFN-\u03b1 production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression","volume":"72","author":"Sisirak","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102033_bib56","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1158\/0008-5472.CAN-12-2271","article-title":"Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells","volume":"72","author":"Conrad","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.smim.2026.102033_bib57","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1158\/2326-6066.CIR-13-0114-T","article-title":"Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL","volume":"1","author":"Aspord","year":"2013","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.smim.2026.102033_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41541-025-01362-z","article-title":"Type I interferon restricts mRNA vaccine efficacy through suppression of antigen uptake in cDCs","volume":"11","author":"Lobb","year":"2026","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.smim.2026.102033_bib59","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/jleuko\/qiad062","article-title":"The development and function of human monocyte-derived dendritic cells regulated by metabolic reprogramming","volume":"114","author":"Zhao","year":"2023","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.smim.2026.102033_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0015-2015","article-title":"Monocyte, Macrophage, and Dendritic Cell Development: the Human Perspective","volume":"4","author":"Collin","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.smim.2026.102033_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70075","article-title":"Monocyte-Derived Dendritic Cells: An Updated View on an Old Concept","volume":"336","author":"Segura","year":"2025","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2026.102033_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/cei.13442","article-title":"Oncolytic adenovirus ORCA-010 increases the type 1 T cell stimulatory capacity of melanoma-conditioned dendritic cells","volume":"201","author":"L\u00f3pez Gonz\u00e1lez","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib63","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200264","article-title":"Tumor-infiltrating dendritic cell states are conserved across solid human cancers","volume":"218","author":"Gerhard","year":"2021","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2026.102033_bib64","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-024-44787-1","article-title":"Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102033_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102350","article-title":"Recent progress in type 1 classical dendritic cell cross-presentation - cytosolic, vacuolar, or both?","volume":"83","author":"Ohara","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib66","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","article-title":"Cross-priming in cancer immunology and immunotherapy","volume":"25","author":"Luri-Rey","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.smim.2026.102033_bib67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13062-023-00430-5","article-title":"Conventional type 1 dendritic cells (cDC1) in cancer immunity","volume":"18","author":"Liu","year":"2023","journal-title":"Biol. Direct"},{"key":"10.1016\/j.smim.2026.102033_bib68","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3389\/fimmu.2020.01276","article-title":"Antigen Cross-Presentation by Macrophages","volume":"11","author":"Muntjewerff","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib69","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib70","doi-asserted-by":"crossref","first-page":"12716","DOI":"10.1073\/pnas.1203468109","article-title":"Cross-dressed CD8\u03b1+\/CD103+ dendritic cells prime CD8+ T cells following vaccination","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.smim.2026.102033_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102331","article-title":"Trogocytosis and cross-dressing in antigen presentation","volume":"83","author":"Schriek","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib72","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3389\/fimmu.2018.01643","article-title":"Current Concepts of Antigen Cross-Presentation","volume":"9","author":"Embgenbroich","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib73","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1108003","article-title":"Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate","volume":"307","author":"Delamarre","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102033_bib74","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2006.05.035","article-title":"NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells","volume":"126","author":"Savina","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.smim.2026.102033_bib75","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ncb1552","article-title":"Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes","volume":"9","author":"Jancic","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.smim.2026.102033_bib76","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1182\/blood-2008-01-134791","article-title":"NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells","volume":"112","author":"Mantegazza","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102033_bib77","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/brv.12140","article-title":"The return of metabolism: biochemistry and physiology of the pentose phosphate pathway","volume":"90","author":"Stincone","year":"2015","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.smim.2026.102033_bib78","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","article-title":"The pentose phosphate pathway in health and disease","volume":"5","author":"TeSlaa","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.smim.2026.102033_bib79","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nri3771","article-title":"Dendritic cell metabolism","volume":"15","author":"Pearce","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001759","article-title":"Direct Type I IFN but Not MDA5\/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation","volume":"12","author":"Pantel","year":"2014","journal-title":"PLOS Biol."},{"key":"10.1016\/j.smim.2026.102033_bib81","first-page":"203","article-title":"Metabolic control of dendritic cell activation and function: recent advances and clinical implications","volume":"5","author":"Everts","year":"2014","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib82","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.cell.2011.11.021","article-title":"Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells","volume":"147","author":"Cebrian","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.smim.2026.102033_bib83","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.adg8802","article-title":"Perforin-2 is a pore-forming effector of endocytic escape in cross-presenting dendritic cells","volume":"380","author":"Rodr\u00edguez-Silvestre","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102033_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adn2168","article-title":"The pore-forming apolipoprotein APOL7C drives phagosomal rupture and antigen cross-presentation by dendritic cells","volume":"9","author":"Gonzales","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib85","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2026.102033_bib86","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance","volume":"196","author":"Bonifaz","year":"2002","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2026.102033_bib87","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.immuni.2015.11.006","article-title":"Toll-like Receptor 4 Engagement on Dendritic Cells Restrains Phago-Lysosome Fusion and Promotes Cross-Presentation of Antigens","volume":"43","author":"Alloatti","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib88","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41419-020-2236-3","article-title":"Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer","volume":"11","author":"Ma","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.smim.2026.102033_bib89","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med"},{"key":"10.1016\/j.smim.2026.102033_bib90","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med"},{"key":"10.1016\/j.smim.2026.102033_bib91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.2007.00573.x","article-title":"The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy","volume":"220","author":"Apetoh","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2026.102033_bib92","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med"},{"key":"10.1016\/j.smim.2026.102033_bib93","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12967-023-04017-6","article-title":"Immunogenic cell death in cancer: concept and therapeutic implications","volume":"21","author":"Galluzzi","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.smim.2026.102033_bib94","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41467-023-35917-2","article-title":"Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102033_bib95","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01897-23","article-title":"Oncolytic Newcastle disease virus induced degradation of YAP through E3 ubiquitin ligase PRKN to exacerbate ferroptosis in tumor cells","volume":"98","author":"Sun","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2026.102033_bib96","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1038\/s41467-022-31218-2","article-title":"Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity","volume":"13","author":"Wiernicki","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102033_bib97","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1084\/jem.20021263","article-title":"ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8\u03b1+ Dendritic Cells","volume":"196","author":"Schiavoni","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2026.102033_bib98","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.immuni.2012.03.008","article-title":"F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells","volume":"36","author":"Ahrens","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib99","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2012.03.009","article-title":"The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments","volume":"36","author":"Zhang","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41590-020-00824-x","article-title":"The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens","volume":"22","author":"Canton","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib101","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4049\/jimmunol.166.3.1439","article-title":"Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo","volume":"166","author":"Kurts","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib102","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3389\/fimmu.2018.03059","article-title":"Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment","volume":"9","author":"Fu","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib103","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-0-12-380995-7.00004-5","article-title":"How tolerogenic dendritic cells induce regulatory T cells","volume":"108","author":"Maldonado","year":"2010","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib104","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1096-1096","article-title":"Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells","volume":"2","author":"Gabrilovich","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2026.102033_bib105","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood-2003-01-0190","article-title":"Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB\/c mice suppresses immune reactivity","volume":"102","author":"Melani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102033_bib106","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1158\/0008-5472.CAN-17-2719","article-title":"Tumor-Derived TGF\u03b2 Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling","volume":"78","author":"Terra","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.smim.2026.102033_bib107","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","article-title":"Tumor-derived lactic acid modulates dendritic cell activation and antigen expression","volume":"107","author":"Gottfried","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102033_bib108","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2567.2004.01988.x","article-title":"Interleukin-10 suppression of myeloid cell activation \u2014 a continuing puzzle","volume":"113","author":"Williams","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.smim.2026.102033_bib109","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41541-025-01219-5","article-title":"Oncolytic virus-mediated p53 activation boosts the antitumor immunity of a p53-transduced dendritic cell vaccine","volume":"10","author":"Yamada","year":"2025","journal-title":"npj Vaccin."},{"key":"10.1016\/j.smim.2026.102033_bib110","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4049\/jimmunol.1302801","article-title":"Oxidized lipids block antigen cross-presentation by dendritic cells in cancer","volume":"192","author":"Ramakrishnan","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib111","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/s41467-017-02186-9","article-title":"Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer","volume":"8","author":"Veglia","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102033_bib112","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.3390\/ijms23094865","article-title":"Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1+ Myeloid Dendritic Cells","volume":"23","author":"Kalus","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.smim.2026.102033_bib113","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.celrep.2016.03.017","article-title":"Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies","volume":"15","author":"Rojas","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.smim.2026.102033_bib114","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood-2006-06-027136","article-title":"Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta","volume":"109","author":"Zhu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102033_bib115","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1128\/JVI.02776-13","article-title":"MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2","volume":"88","author":"Davies","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2026.102033_bib116","doi-asserted-by":"crossref","first-page":"37692","DOI":"10.1074\/jbc.M105927200","article-title":"Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells","volume":"276","author":"Re","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2026.102033_bib117","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.291.5508.1544","article-title":"Induction of Direct Antimicrobial Activity Through Mammalian Toll-Like Receptors","volume":"291","author":"Thoma-Uszynski","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102033_bib118","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ccell.2020.12.022","article-title":"Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective","volume":"39","author":"Ramelyte","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.smim.2026.102033_bib119","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/bjh.17173","article-title":"Oncolytic herpes simplex virus type 1 (HSV-1) in combination with lenalidomide for plasma cell neoplasms","volume":"192","author":"Oku","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.smim.2026.102033_bib120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni.1602","article-title":"Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I","volume":"9","author":"Di Pucchio","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib121","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1128\/JVI.78.10.5223-5232.2004","article-title":"Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells","volume":"78","author":"Fonteneau","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2026.102033_bib122","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood-2006-07-034785","article-title":"HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells","volume":"109","author":"Boasso","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102033_bib123","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/leu.2015.11","article-title":"Targeting PD1\u2013PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells","volume":"29","author":"Ray","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.smim.2026.102033_bib124","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1182\/blood-2009-04-217927","article-title":"Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients","volume":"114","author":"Stary","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102033_bib125","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1158\/0008-5472.CAN-18-0933","article-title":"Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming","volume":"78","author":"S\u00e1nchez-Paulete","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.smim.2026.102033_bib126","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001621","article-title":"Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB\u2013IVM1c melanoma","volume":"9","author":"Malvehy","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102033_bib127","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005141","article-title":"Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial","volume":"10","author":"Schwarze","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102033_bib128","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-024-00760-x","article-title":"An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy","volume":"5","author":"Chen","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.smim.2026.102033_bib129","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.4049\/jimmunol.180.6.3857","article-title":"Memory CD8+ T Cells Protect Dendritic Cells from CTL Killing","volume":"180","author":"Watchmaker","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.immuni.2013.08.034","article-title":"Antigen availability determines CD8+ T cell-dendritic cell interaction kinetics and memory fate decisions","volume":"39","author":"Henrickson","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib131","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2014.02.004","article-title":"Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8(+) T cell differentiation by a CD24-dependent mechanism","volume":"40","author":"Kim","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib132","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1038\/s41467-019-12319-x","article-title":"Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells","volume":"10","author":"Menares","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102033_bib133","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","article-title":"Inflammation Directs Memory Precursor and Short-Lived Effector CD8(+) T Cell Fates via the Graded Expression of T-bet Transcription Factor","volume":"27","author":"Joshi","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib134","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.4049\/jimmunol.0901203","article-title":"A Default Pathway of Memory CD8 T Cell Differentiation after Dendritic Cell Immunization Is Deflected by Encounter with Inflammatory Cytokines during Antigen-Driven Proliferation1","volume":"183","author":"Pham","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib135","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0171-2985(98)80075-2","article-title":"Human dendritic cells express functional interleukin-7","volume":"198","author":"Sorg","year":"1998","journal-title":"Immunobiology"},{"key":"10.1016\/j.smim.2026.102033_bib136","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1182\/blood-2008-05-156307","article-title":"Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation","volume":"112","author":"Stonier","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102033_bib137","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.4049\/jimmunol.1203149","article-title":"CD8\u03b1+ dendritic cell trans presentation of IL-15 to naive CD8+ T cells produces antigen-inexperienced T cells in the periphery with memory phenotype and function","volume":"190","author":"Sosinowski","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib138","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ni1513","article-title":"Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells","volume":"8","author":"Link","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib139","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41590-022-01131-3","article-title":"Tcf1 preprograms the mobilization of glycolysis in central memory CD8+ T cells during recall responses","volume":"23","author":"Shan","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib140","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.immuni.2021.08.026","article-title":"Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes","volume":"54","author":"Schenkel","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib141","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41541-024-00856-6","article-title":"Immunization-induced antigen archiving enhances local memory CD8+ T cell responses following an unrelated viral infection","volume":"9","author":"Doan","year":"2024","journal-title":"npj Vaccin."},{"key":"10.1016\/j.smim.2026.102033_bib142","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-025-58289-1","article-title":"Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse","volume":"16","author":"Heras-Murillo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102033_bib143","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg7836","article-title":"A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response","volume":"6","author":"Connolly","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib144","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000867","article-title":"Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy","volume":"8","author":"Buchwald","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102033_bib145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/intimm\/dxaf003","article-title":"Beneficial effects on T cells by photodynamic therapy with talaporfin enhance cancer immunotherapy","volume":"37","author":"Ezzaldeen","year":"2025","journal-title":"Int Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib146","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1038\/s41467-024-49873-y","article-title":"Delayed tumor-draining lymph node irradiation preserves the efficacy of combined radiotherapy and immune checkpoint blockade in models of metastatic disease","volume":"15","author":"Telarovic","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102033_bib147","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008026","article-title":"Tumor-draining lymph nodes: opportunities, challenges, and future directions in colorectal cancer immunotherapy","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102033_bib148","doi-asserted-by":"crossref","first-page":"12160","DOI":"10.1128\/JVI.05703-11","article-title":"Vesicular Stomatitis Virus Oncolytic Treatment Interferes with Tumor-Associated Dendritic Cell Functions and Abrogates Tumor Antigen Presentation","volume":"85","author":"Leveille","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2026.102033_bib149","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2017.08.027","article-title":"Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy","volume":"170","author":"Ribas","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.smim.2026.102033_bib150","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/1078-0432.CCR-12-2546","article-title":"Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus","volume":"19","author":"Kanerva","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.smim.2026.102033_bib151","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1158\/1078-0432.CCR-18-1932","article-title":"Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade","volume":"25","author":"Chon","year":"2019","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.smim.2026.102033_bib152","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/1078-0432.CCR-20-2400","article-title":"Modification of extracellular matrix enhances oncolytic adenovirus immunotherapy in glioblastoma","volume":"27","author":"Kiyokawa","year":"2021","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.smim.2026.102033_bib153","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nm.3089","article-title":"Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer","volume":"19","author":"Heo","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2026.102033_bib154","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/eji.200635993","article-title":"Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses","volume":"36","author":"Fink","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.omtm.2022.12.013","article-title":"Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication","volume":"28","author":"Dambra","year":"2023","journal-title":"Mol. Ther. - Methods & Clin. Dev."},{"key":"10.1016\/j.smim.2026.102033_bib156","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/JVI.00074-14","article-title":"Vesiculovirus Neutralization by Natural IgM and Complement","volume":"88","author":"Tesfay","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2026.102033_bib157","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/mt.2015.49","article-title":"Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques","volume":"23","author":"Evgin","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.smim.2026.102033_bib158","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1128\/JVI.02832-12","article-title":"PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice","volume":"87","author":"Tesfay","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2026.102033_bib159","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.22","article-title":"A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity","volume":"3","author":"Nosaki","year":"2016","journal-title":"Mol. Ther. - Oncolytics"},{"key":"10.1016\/j.smim.2026.102033_bib160","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1158\/1078-0432.CCR-12-0979","article-title":"A novel therapeutic regimen to eradicate established solid tumors with an effective induction of tumor-specific immunity","volume":"18","author":"Tysome","year":"2012","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.smim.2026.102033_bib161","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/gt.2016.70","article-title":"Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy","volume":"24","author":"Ilett","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.smim.2026.102033_bib162","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4049\/jimmunol.2000928","article-title":"Vaccinia Virus Infection Inhibits Skin Dendritic Cell Migration to the Draining Lymph Node","volume":"206","author":"Aggio","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib163","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.4049\/jimmunol.163.12.6762","article-title":"Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion","volume":"163","author":"Engelmayer","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib164","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1128\/JVI.00264-12","article-title":"Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation","volume":"86","author":"Guzman","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2026.102033_bib165","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3390\/ijms23031754","article-title":"A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner","volume":"23","author":"El-Sayes","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.smim.2026.102033_bib166","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 Deficiency Reveals a Critical Role for CD8\u03b1+ Dendritic Cells in Cytotoxic T Cell Immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102033_bib167","article-title":"Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer","volume":"10","author":"Vloten","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102033_bib168","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.immuni.2022.09.015","article-title":"Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing","volume":"55","author":"MacNabb","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102033_bib169","article-title":"Engineered oncolytic virus oHSV2-FLT3L enhances antitumor immunity via dendritic cell activation","volume":"33","author":"Wan","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.smim.2026.102033_bib170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/gt.2013.73","article-title":"CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging","volume":"21","author":"Parviainen","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.smim.2026.102033_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102151","article-title":"Oncolytic vaccinia virus armed with 4\u20131BBL elicits potent and safe antitumor immunity and enhances the therapeutic efficiency of PD-1\/PD-L1 blockade in a pancreatic cancer model","volume":"50","author":"Ju","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.smim.2026.102033_bib172","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib173","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","article-title":"Metabolic Instruction of Immunity","volume":"169","author":"Buck","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.smim.2026.102033_bib174","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cmet.2020.09.013","article-title":"Immunometabolism in the Single-Cell Era","volume":"32","author":"Artyomov","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.smim.2026.102033_bib175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","article-title":"SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity","volume":"620","author":"Guo","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102033_bib176","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.smim.2026.102033_bib177","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nri3771","article-title":"Dendritic cell metabolism","volume":"15","author":"Pearce","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib178","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.7150\/jca.27279","article-title":"Oncogenic virus-induced aerobic glycolysis and tumorigenesis","volume":"9","author":"Yu","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.smim.2026.102033_bib179","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41423-021-00753-1","article-title":"Metabolic programming in dendritic cells tailors immune responses and homeostasis","volume":"19","author":"M\u00f8ller","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.smim.2026.102033_bib180","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor\u2013induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102033_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2026.117149","article-title":"Subversion of kynurenine-induced AHR activation in CD8 T cells by kynureninase-expressing antigen-presenting cells","volume":"45","author":"Giacomantonio","year":"2026","journal-title":"Cell Rep."},{"key":"10.1016\/j.smim.2026.102033_bib182","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","article-title":"Modulation of T cells by tryptophan metabolites in the kynurenine pathway","volume":"44","author":"Stone","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.smim.2026.102033_bib183","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00262-016-1820-y","article-title":"Tumor-derived factors modulating dendritic cell function","volume":"65","author":"Zong","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.smim.2026.102033_bib184","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301947RR","article-title":"Does oncolytic viruses-mediated metabolic reprogramming benefit or harm the immune microenvironment?","volume":"38","author":"Peng","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2026.102033_bib185","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.3390\/v7122953","article-title":"Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy","volume":"7","author":"Kim","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.smim.2026.102033_bib186","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004935","article-title":"Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry","volume":"10","author":"Nguyen","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102033_bib187","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.canlet.2021.09.012","article-title":"IDO1\/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer","volume":"522","author":"Liang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.smim.2026.102033_bib188","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25065-w","article-title":"Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model","volume":"12","author":"Abdelmoneim","year":"2022","journal-title":"Sci. Rep."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:24Z","timestamp":1792787904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532326000205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":188,"alternative-id":["S1044532326000205"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2026.102033","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cells as central coordinators of oncolytic virus-induced antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2026.102033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102033"}}